S
Sano Genetics
Biotech & Life Sciences · Cambridge, United Kingdom · Founded 2016
Building the future of precision medicine with genomics MoreLess
Sano Genetics operates in the precision medicine research industry, providing a comprehensive platform that integrates genetic testing, participant recruitment, and long-term engagement to accelerate clinical trials. The company serves pharmaceutical companies, biotech firms, and academic researchers who are conducting personalized medicine studies. Sano's platform simplifies the complex process of DNA testing studies, making it more efficient and cost-effective. The business model is based on offering a tech-forward, user-friendly solution that de-risks trials, enabling clinical operations teams to move 10 times faster and reduce costs by 5 times. Revenue is generated through subscription fees and service charges for the use of their platform and additional support services. Sano's approach is human-centric, focusing on making research engaging, transparent, and meaningful for participants. The company also offers electronic medical record retrieval, providing up to seven years of curated medical history to support research efforts.
Keywords: precision medicine, genetic testing, clinical trials, participant recruitment, long-term engagement, DNA sequencing, biotech, pharmaceutical, personalized medicine, research platform.
Company overview
Sano Genetics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2016
- Headquarters
- Cambridge, United Kingdom
- Employees
- 51
- Open positions
- None listed
- Dealroom signal
- 61.9
Valuation & funding
Sano Genetics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Other✓Other financing | Jul 2024 | $0 | — | PharmStars | ↗ |
| EARLY VC✓Equity / VC | Jan 2024 | $12M | $47M | Plural | ↗ |
| GRANT✓Other financing | Aug 2023 | $436K | — | Undisclosed | ↗ |
| SERIES A✓Equity / VC | Feb 2022 | $11M | $44M | Seedcamp · Gousto · Episode 1 Ventures · Paul Forster | ↗ |
| EARLY VC✓Equity / VC | Jan 2021 | $3.3M | $13M | January Ventures · Seedcamp · Episode 1 Ventures · Cambridge Enterprise | — |
| SUPPORT PROGRAM✓Other financing | Jan 2020 | Google for Startups Accelerator | — | ||
| SEED✓Equity / VC | Apr 2019 | Paul Forster · Cambridge Enterprise · Seedcamp · Will Neale | — | ||
| SUPPORT PROGRAM✓Other financing | Jan 2019 | KQ Labs | — | ||
| SEED✓Equity / VC | May 2018 | Seedcamp | — | ||
| GRANTOther financing | May 2017 | Cambridge University Entrepreneurs | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 51 |
| 2025 | 89 |
| 2024 | 89 |
| 2023 | 65 |
| 2022 | 46 |
| 2021 | 25 |
| 2020 | 18 |
Growth signals
Sano Genetics website traffic
Latest recorded traffic for Sano Genetics is 13K monthly website visits, down 7.1% over the last three months. Sano Genetics's team declined 42.7% over the past year.
Comparisons
Sano Genetics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Sano Genetics's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Sano Genetics has talent and traffic
team presence
In the news
Latest news about Sano Genetics
Recent press, funding announcements, and product moves mentioning Sano Genetics — open to read from the original sources.
Market sentiment
What the market is saying about Sano Genetics
An AI-synthesized read of the highest-engagement posts about Sano Genetics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sano Genetics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.